Covered recipient · General Payments record
SHAKIR ALATTAR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$995.03
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $340.37 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $185.08 | 8 |
| Astellas Pharma US Inc | $46.83 | 2 |
| Lilly USA, LLC | $38.11 | 2 |
| Abbott Laboratories | $18.64 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.42 | 1 |
| Novo Nordisk AS | $18.05 | 1 |
| GlaxoSmithKline, LLC. | $15.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.64 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125015891 | CMS |
| Astellas Pharma US Inc | $21.95 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139341744 | CMS |
| Astellas Pharma US Inc | $24.88 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139446338 | CMS |
| Dexcom, Inc. | $33.87 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335533 | CMS |
| Dexcom, Inc. | $21.79 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335535 | CMS |
| Dexcom, Inc. | $20.14 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335537 | CMS |
| Dexcom, Inc. | $19.12 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335539 | CMS |
| Dexcom, Inc. | $22.78 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335541 | CMS |
| Dexcom, Inc. | $22.09 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335543 | CMS |
| Dexcom, Inc. | $22.04 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335545 | CMS |
| Dexcom, Inc. | $23.25 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335547 | CMS |
| GlaxoSmithKline, LLC. | $15.24 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116246376 | CMS |
| Lilly USA, LLC | $20.15 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135422679 | CMS |
| Lilly USA, LLC | $17.96 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135424307 | CMS |
| Novo Nordisk Inc | $18.05 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097434878 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.42 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151033494 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.